📢#RCM-Vol. 25 No. 1 Review Role of Estimated Glomerular Filtration Rate in Clinical Research: The Never-Ending Matter ✅by Abenavoli et al. imrpress.com/journal/RCM/25… #CardioTwitter #cardiovascular #Cardiology #cardiac #Research #MedEd #CardioEd #2024Review

JAMA Insights reviews the origin of APOL1 high-risk genetic variants, defines APOL1-mediated kidney disease, and discusses recommendations for screening and management. ja.ma/3WfiAYJ

Note the GFR slope even by Cystatin C So not about loss of muscle mass FLOW at #ERA24

Katharina Mayer from MedUni Wien is presenting study data of Felzartamab targeting CD38 in ABMR after kidney transplantation! Impressive data! Congratulations!!!! #ERA24

Hamburg-한국사랑 news: Now out NEJM, the international collaborative study on the clinical and pathophysiological role of anti-nephrin autoantibodies in podocytopathies nejm.org/doi/full/10.10… International Society of Glomerular Disease @hckh_hamburg UKE Hamburg Tobias B. Huber Nicola M. Tomas Felicitas Hengel

Don't stop the FLOW after #ERA24! A Markus@Home with Profs Katherine Tuttle Valerie Luyckx and Tobias B. Huber on key studies presented during the past meeting in Stockholm! For those who missed the FLOW trial presentation and the anti-nephrin AB story. youtube.com/watch?v=1MfPgH…

Another emerging story in nephrology: Risk prediction is coming of age, especially with a 1A rec in KDIGO 2024 guidelines Great working with Navdeep Tangri to validate the Klinrisk algorithm in the CANVAS & CREDENCE trials Open access: …ubs.pericles-prod.literatumonline.com/doi/10.1111/do… More coming soon

Die Flyer der ÖGN - Österreichische Gesellschaft für Nephrologie nieren.app sind fertig!!!

Nephrology Hub Ottakring Vienna

New Global Trial Focus is out!🫘 Including Cemdisiran Phase 2 Trial, AURORA 1 & VALOR-CKD Dominik theisn.org/in-action/rese…

Nonlupus full house nephropathy is a rare, complex entity. This study supports that SLE and nonlupus full house nephropathy are distinct clinical entities, with comparable outcomes bit.ly/CJASN0438 Andreas Kronbichler

Lively debates at Nephrologie Update 2.4 Schladming Kathrin Eller Alexander Kirsch Jan T Kielstein Konstantin Klötzer marcus_saemann - looking forward to day 2 starting with Marlies Antlanger Emanuel Zitt

Heutiger Vortrag für NostrifikantInnen in der Ärztekammer für Wien zu den Themen AKI, CKD, BGA und Elektrolytstörungen 🫘

Now open access in NDT Global Burden of Disease Study – a kidney disease data base 😬GBD2021 found CKD to be the 11th leading cause of death and kidney dysfunction to be the 8th leading cause of DALYs ▶️academic.oup.com/ndt/article/do…

PotW#43 Der FLOW Trial untersuchte die Efficacy und Safety von Semaglutid 1x/Wo gg. Placebo auf das Auftreten kardiorenaler Events bei DM2 und diabet. CKD Kurz gesagt...Frühzeitiger Studienabbruch wegen überzeugender Daten Link z PotW: 🖇️ pdf.ac/3Ueq71 Azra Zukic

Sehr stolz auf das von den Young Nephrologists Austria erstellte NephroScript✨️👏 Danke für die Möglichkeit😊 ÖGN - Österreichische Gesellschaft für Nephrologie Kathrin Eller MedMedia Simon Aberger

New study on SGLT2i in patients without T2D regardless of albuminuria level✨️ Currently KDIGO only recommends SGLT2i in eGFR <45 in non-T2D patients with low albuminuria...👀 CKJ (OPTIMISE-CKD) academic.oup.com/ckj/article/17…

Das Update der nieren.app ist live!✨️ Was ist neu? 1) Suchfunktion in den Guidelines 2) 40% GFR Decline Rechner 3) aktuelle Heatmap Neu installieren und gleich ausprobieren🫘 ÖGN - Österreichische Gesellschaft für Nephrologie marcus_saemann Young Nephrologists Austria